This document is an excerpt from the EUR-Lex website
Document C2007/082/105
Case T-48/07: Action brought on 21 February 2007 — ratiopharm v OHIM (BioGeneriX)
Case T-48/07: Action brought on 21 February 2007 — ratiopharm v OHIM (BioGeneriX)
Case T-48/07: Action brought on 21 February 2007 — ratiopharm v OHIM (BioGeneriX)
SL C 82, 14.4.2007, p. 50–51
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, RO, SK, SL, FI, SV)
|
14.4.2007 |
EN |
Official Journal of the European Union |
C 82/50 |
Action brought on 21 February 2007 — ratiopharm v OHIM (BioGeneriX)
(Case T-48/07)
(2007/C 82/105)
Language of the case: German
Parties
Applicant: ratiopharm GmbH (Ulm, Germany) (represented by S. Völker, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)
Form of order sought
The applicant claims that the Court should
|
— |
annul the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 20 December 2006 in Case R 1048/2004-4 concerning the application for Community trade mark No 002603124; |
|
— |
order the Office for Harmonisation in the Internal Market to pay the costs of the proceedings. |
Pleas in law and main arguments
Community trade mark concerned: Word mark ‘BioGeneriX ’for goods in Classes 1 and 5 (Application No 2 603 124).
Decision of the Examiner: Refusal of part of the application for registration.
Decision of the Board of Appeal: Appeal dismissed.
Pleas in law: Breach of Article 7(1)(b) and (c) of Regulation (EC) No 40/94 (1), as the trade mark applied for has the requisite minimum level of distinctiveness and there is no need to preserve its availability.
(1) Council Regulation (EC) No 40/94 of 20 December 1993 on the Community trade mark (OJ 1994 L 11, p. 1).